1,142
Views
1
CrossRef citations to date
0
Altmetric
Editorial

How can the new antipsychotic medications improve quality of life in patients with schizophrenia?

Pages 1709-1711 | Received 01 Jul 2016, Accepted 18 Jul 2016, Published online: 29 Jul 2016

References

  • Karow A, Wittmann L, Schöttle D, et al. Dialogues. Clin Neurosci. 2014;16(2):185–195.
  • NICE Guidance. Psychosis and schizophrenia in adults: prevention and management. NICE guidelines [CG178]. [ cited 2014 Mar] Available from: https://www.nice.org.uk/guidance/cg178
  • European Network for Health Technology Assessment. HTA core model for rapid relative effectiveness. Cited 2015 Nov. Available from: http://www.eunethta.eu/outputs/hta-core-model-rapid-rea
  • Chue P, Procyshyn RM. Pharmacotherapy in real-world patients with schizophrenia. Toronto (ON): Elsevier Canada. Clinical Companion; 2009.
  • Nasrallah HA, Targum SD, Tandon R, et al. Defining and measuring clinical effectiveness in the treatment of schizophrenia. Psychiatr Serv. 2005;56(3):273–282.
  • Saxena S, Orley J; WHOQOL Group. Quality of life assessment: the world health organisation perspective. Eur Psychiatry. 1997;12(3):263–266.
  • Nakagawa S, Hayashi N. Clinical correlates of objective and subjective quality of life among middle-aged and elderly female inpatients with chronic schizophrenia. Asian J Psychiatr. 2013;6(5):389–393.
  • Hayhurst KP, Massie JA, Dunn G, et al. Validity of subjective versus objective quality of life assessment in people with schizophrenia. BMC Psychiatry. 2014;14:365.
  • Tomotake M. Quality of life and its predictors in people with schizophrenia. Med Invest. 2011;58:167–174. .
  • Zhang JP, Gallego JA, Robinson DG, et al. Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis. Int J Neuropsychopharmacol. 2013;16(6):1205–1218.
  • Jones PB, Barnes TR, Davies L, et al. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry. 2006;63(10):1079–1087.
  • Swartz MS, Perkins DO, Stroup TS, et al. CATIE Investigators. Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study. Am J Psychiatry. 2007;164(3):428–436.
  • Fervaha G, Agid O, Takeuchi H, et al. Effect of antipsychotic medication on overall life satisfaction among individuals with chronic schizophrenia: findings from the NIMH CATIE study. Eur Neuropsychopharmacol. 2014;24(7):1078–1085.
  • Gründer G, Heinze M, Cordes J, et al. NeSSy Study Group. Effects of first-generation antipsychotics versus second-generation antipsychotics on quality of life in schizophrenia: a double-blind, randomised study. Lancet Psychiatry. 2016 Jun 2.
  • Naber D, Hansen K, Forray C, et al. Qualify: a randomized head-to-head study of aripiprazole once-monthly and paliperidone palmitate in the treatment of schizophrenia. Schizophr Res. 2015;168(1–2):498–504.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.